Tag Archives: cell

Bristol Myers, hot off Breyanzi nod, plots new cell therapy factory in Massachusetts

Bristol Myers Squibb, freshly armed with an approval for its CAR-T lymphoma therapy Breyanzi, is making a major cell therapy manufacturing play. The company is building out a new 244,000-square-foot cell therapy site, housed at the company’s 89-acre campus in Devens, Massachusetts. The new factory will be kitted out to quickly ramp up clinical and commercial production, augmenting Bristol’s existing… Read More »

Novel adoptive cell transfer method shortens timeline for T-cell manufacture

Adoptively transferred T-cells can prolong survival and sometimes cure patients with advanced solid tumors. While promising, it can take months to generate the necessary T-cells to help these patients. Such slow speed makes this therapy impractical for most patients who need immediate treatment. In the September issue of Cancer Research, Hannah Knochelmann, a student in… Read More »

Small Cell Forum Shows Leveraging Edge and Small Cell Synergies Optimizes Value For Service Providers and Enterprises

New analysis outlines significant market opportunities and details work required to realize the potential of combined small cell/edge solutions London, UK, 10th June 2020 Small Cell Forum (SCF) today published research setting out how edge computing will impact the future of small cell networks, with particular focus on private cellular networks. A survey of service… Read More »

BCG vaccine helps fight infections by boosting immune cell production

By Layal Liverpool BCG vaccine (red, lower left) infecting a human white blood cell (green)NIBSC/SCIENCE PHOTO LIBRARY The BCG (Bacillus Calmette-Guérin) tuberculosis vaccine boosts the production of immune cells, which may explain why it can protect newborn babies from dying of sepsis. Previous studies have shown that BCG vaccination can protect newborns against a broad… Read More »

‘Executioner cell’ find may help to treat the causes of blindness

Researchers at Trinity College Dublin have identified a so-called “executioner cell” that may hold the key to eventually finding a treatment to slow retinal degeneration that causes blindness in millions of people each year. A multi-disciplinary team involving experts from TCD believe they have pinpointed a potential new therapeutic target for treating retinal degeneration. It… Read More »

Imfinzi (durvalumab) Approved in the US for Extensive-Stage Small Cell Lung Cancer

Print this page 30 March 2020 — AstraZeneca’s Imfinzi (durvalumab) has been approved in the US as a 1st-line treatment for adult patients with extensive-stage small cell lung cancer (ES-SCLC) in combination with standard-of-care (SoC) chemotherapies, etoposide plus either carboplatin or cisplatin (platinum-etoposide). The approval by the Food and Drug Administration was based on positive results from… Read More »